Announcements

Chiasma seeks US FDA marketing approval for octreotide to treat acromegaly

Chiasma files for $86m Nasdaq IPO

Facing Your Body Image Demons - Read the article here!

Chiasma Announces New Data for Investigational Octreotide Capsules. Read all about it by clicking here...

Ipsen Announces FDA Approval of a New Delivery Device for Somatuline Depot (Lanreotide) injection. Read all about it by clicking here...